These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 12925138)

  • 41. Lymphotoxin β receptor signalling executes
    Mejías-Luque R; Zöller J; Anderl F; Loew-Gil E; Vieth M; Adler T; Engler DB; Urban S; Browning JL; Müller A; Gerhard M; Heikenwalder M
    Gut; 2017 Aug; 66(8):1369-1381. PubMed ID: 27196595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PUMA-mediated epithelial cell apoptosis promotes Helicobacter pylori infection-mediated gastritis.
    Dang Y; Zhang Y; Xu L; Zhou X; Gu Y; Yu J; Jin S; Ji H; Shu Y; Zhang G; Cui S; Sun J
    Cell Death Dis; 2020 Feb; 11(2):139. PubMed ID: 32080167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concentrations of gastric mucosal cytokines in children with food allergy and Helicobacter pylori infection.
    Maciorkowska E; Panasiuk A; Kaczmarsk M
    World J Gastroenterol; 2005 Nov; 11(43):6751-6. PubMed ID: 16425379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
    Yamamichi N; Oka M; Inada K; Konno-Shimizu M; Kageyama-Yahara N; Tamai H; Kato J; Fujishiro M; Kodashima S; Niimi K; Ono S; Tsutsumi Y; Ichinose M; Koike K
    Biochem Biophys Res Commun; 2012 Jul; 424(1):124-9. PubMed ID: 22732404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.
    Nardone G; Staibano S; Rocco A; Mezza E; D'armiento FP; Insabato L; Coppola A; Salvatore G; Lucariello A; Figura N; De Rosa G; Budillon G
    Gut; 1999 Jun; 44(6):789-99. PubMed ID: 10323879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract.
    Genta RM
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():8-13. PubMed ID: 12925136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PBX1 attributes as a determinant of connexin 32 downregulation in
    Liu XM; Xu CX; Zhang LF; Huang LH; Hu TZ; Li R; Xia XJ; Xu LY; Luo L; Jiang XX; Li M
    World J Gastroenterol; 2017 Aug; 23(29):5345-5355. PubMed ID: 28839434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
    Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
    J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide.
    Haruma K; Ito M
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():153-9. PubMed ID: 12925154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
    Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
    Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
    Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
    Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation.
    Li GQ; Xia HH; Chen MH; Gu Q; Wang JD; Peng JZ; Chan AO; Cho CH; So HL; Lam SK; Hu PJ; Liang YJ; Lin HL; Berg DE; Feng ZH; Langenbach R; Wong BC
    J Infect Dis; 2006 Apr; 193(7):1037-46. PubMed ID: 16518767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
    Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
    Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
    Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.
    Smythies LE; Waites KB; Lindsey JR; Harris PR; Ghiara P; Smith PD
    J Immunol; 2000 Jul; 165(2):1022-9. PubMed ID: 10878379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
    Kim J; Kim K; Lee JS; Kim SY; Kim KO; Kim YJ; Kwon KA; Park DK; Chung JW
    Korean J Gastroenterol; 2018 Apr; 71(4):204-212. PubMed ID: 29684969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling.
    Jones NL; Day AS; Jennings H; Shannon PT; Galindo-Mata E; Sherman PM
    Infect Immun; 2002 May; 70(5):2591-7. PubMed ID: 11953400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.